Home / Specialties / Hematology & CAR-T
Specialty guide · 血液科

Blood disorder and blood cancer care in China

Considering blood-disorder or blood-cancer care in China? Start with source pathology or marrow reports, laboratory trends and previous regimens. Explore specialist review, transplant or cellular-therapy assessment around the exact diagnosis. Product access, centre eligibility and a proposed treatment plan must be confirmed for the individual case before travel.

10care guides
3clear care groups
10ranked centers shown
2026page reviewed
Hematology & CAR-T care team in a modern Chinese hospital

Before arranging hematology & car-t in China

Explain your main question and prepare the blood or marrow diagnosis, previous regimens and response history.

Start with a clear review question

Tell us the diagnosis if known, what you have already tried and which reports are available. We help identify the relevant specialist pathway and records needed for hospital review.

Confirm the assessment and estimate

Ask the centre which review route is available, whether the particular treatment is appropriate and how caregiver support, admission and continuing monitoring would be coordinated. Hospital acceptance, the actual clinical scope and any separately agreed coordination fee need confirmation before booking.

Choose the next step that fits

You can enquire about an opinion, a specialist appointment or treatment arrangements. An optional records-based specialist review is agreed separately; an initial enquiry does not commit you to a paid service.

Care map

Start with the right clinical question

Use these four points to organize the case before comparing hospitals, techniques or travel plans.

ClassificationFlow cytometry, marrow studies and genetics define the disease.
Treatment historyResponse and toxicity from every prior line influence next steps.
EligibilityCAR-T and transplant require separate medical and logistical screening.
ContinuityMonitoring and urgent support must continue after returning home.
Care directory

Find the relevant care pathway

Explore the guides below to prepare records, compare the care pathways and identify questions for specialist review.

Hematology & CAR-T specialist explaining imaging and treatment planning to an international patient
Hematology & CAR-T reviewInclude morphology, flow, cytogenetics, molecular tests and original reports. List medicines, dates, response, relapse and major complications.
Planning framework

Prepare the case before choosing a center

1

Send marrow and pathology data

Include morphology, flow, cytogenetics, molecular tests and original reports.

2

Map every treatment line

List medicines, dates, response, relapse and major complications.

3

Plan beyond the procedure

Confirm donor or cell logistics, infection care and long-term monitoring.

Hematology & CAR-T specialist reviewing a care plan with an international patient
Case review and practical planningConfirm donor or cell logistics, infection care and long-term monitoring. Monitoring and urgent support must continue after returning home.
2023 Fudan specialty reputation reference

Top 10 hospitals for hematology & car-t in China

The published specialty ranking is a useful starting point. The right match still depends on the exact diagnosis, subspecialist, clinician experience and current access.

1

Peking University People’s Hospital

北京大学人民医院
Beijing
2

Institute of Hematology, CAMS

中国医学科学院血液病医院(研究所)
Tianjin
3

Ruijin Hospital, Shanghai Jiao Tong University

上海交通大学医学院附属瑞金医院
Shanghai
4

First Affiliated Hospital of Soochow University

苏州大学附属第一医院
Suzhou
5

Wuhan Union Hospital

华中科技大学同济医学院附属协和医院
Wuhan
Show hospitals ranked 6–10
6

First Affiliated Hospital, Zhejiang University

浙江大学医学院附属第一医院
Hangzhou
7

Nanfang Hospital, Southern Medical University

南方医科大学南方医院
Guangzhou
8

Peking Union Medical College Hospital

中国医学科学院北京协和医院
Beijing
9

Xinqiao Hospital, Army Medical University

陆军军医大学第二附属医院(新桥医院)
Chongqing
10

Qilu Hospital of Shandong University

山东大学齐鲁医院
Jinan
Specialty reputation is not a procedure ranking

Use the list as a starting point. Confirm the relevant unit, clinician experience, treatment access and expected pathway after record review.